CD133-positive tumor cells enable the DNA damage checkpoint in feedback to radiation and a more effective fix for radiation-induced DNA damage, which may cause, at least in part, the radioresistance of CD133-positive glioma-initiating cells (GICs) [69,70]. This evidence concerns the gene PROM1 and central nervous system cancer.